Research ArticleClinical Practice Guideline
AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients
Shawna L Strickland, Bruce K Rubin, Carl F Haas, Teresa A Volsko, Gail S Drescher and Catherine A O'Malley
Respiratory Care July 2015, 60 (7) 1071-1077; DOI: https://doi.org/10.4187/respcare.04165
Shawna L Strickland
American Association for Respiratory Care, Irving, Texas.
PhD RRT-NPS ACCS AE-C FAARCBruce K Rubin
Children's Hospital of Richmond, Virginia Commonwealth University, Richmond, Virginia.
MD MEngr MBA FAARCCarl F Haas
University of Michigan Health System, Ann Arbor, Michigan.
MLS RRT-ACCS FAARCTeresa A Volsko
Department of Respiratory Care, Akron Children's Hospital, Akron, Ohio.
MHHS RRT FAARCGail S Drescher
MedStar Washington Hospital Center, Washington DC.
MA RRTCatherine A O'Malley
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois.
RRT-NPSArticle Figures & Data
Tables
In this issue
Respiratory Care
Vol. 60, Issue 7
1 Jul 2015
AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients
Shawna L Strickland, Bruce K Rubin, Carl F Haas, Teresa A Volsko, Gail S Drescher, Catherine A O'Malley
Respiratory Care Jul 2015, 60 (7) 1071-1077; DOI: 10.4187/respcare.04165
Jump to section
- Article
- Abstract
- Introduction
- Assessment of Evidence
- Hospitalized Adult and Pediatric Patients Without Cystic Fibrosis
- Adult and Pediatric Patients With Neuromuscular Disease, Respiratory Muscle Weakness, or Impaired Cough
- Postoperative Adult and Pediatric Patients
- Physical and Financial Harmful Effects
- Discussion
- Implications and Directions for Future Research
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- References